The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-10 of 10 articles
Impact of ticagrelor monotherapy on two-year clinical outcomes in patients with long stenting: a post hoc analysis of the GLOBAL LEADERS trial
Takahashi K,
Chichareon P,
Modolo R,
Kogame N,
Chang C,
Tomaniak M,
Moschovitis A,
Curzen N,
Haude M,
Jung W,
Holmvang L,
Garg S,
Tijssen J,
Wykrzykowska JJ,
de Winter R,
Hamm C,
Steg G,
Stoll H,
Onuma Y,
Valgimigli M,
Vranckx P,
Windecker S,
Serruys P
October 23, 2020 | 10.4244/EIJ-D-19-00498
Establishment of healing profile and neointimal transformation in the new polymer-free biolimus A9-coated coronary stent by longitudinal sequential optical coherence tomography assessments: the EGO-BIOFREEDOM study
Lee WLS,
Tam FCC,
Chan KKW,
Lam S,
Kong S-L,
Shea CP,
Wong MKL,
Wong AYT,
Yung ASY,
Zhang L-W,
Lam Y-M,
Mintz GS,
Costa R,
Stoll H,
Maehara A
September 20, 2018 | 10.4244/EIJ-D-18-00061
Biolimus A9 polymer-free coated stents in high bleeding risk patients undergoing complex PCI: evidence from the LEADERS FREE randomised clinical trial
Lipiecki J,
Brunel P,
Morice M,
Roguelov C,
Walsh S,
Richardt G,
Eerdmans P,
Zambahari R,
Berland J,
Copt S,
Stoll H,
Urban P
July 20, 2018 | 10.4244/EIJ-D-18-00293
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
Jensen C,
Naber CK,
Urban P,
Ong P,
Valdés Chávarri M,
Abizaid A,
Pocock S,
Fabbiocchi F,
Dubois C,
Copt S,
Stoll H,
Morice M
March 20, 2018 | 10.4244/EIJ-D-17-00720
Outcomes in patients undergoing multivessel percutaneous coronary intervention using sirolimus-eluting stents: a report from the e-SELECT registry
Cuculi F,
Banning A,
Abizaid A,
Bartorelli AL,
Baux A,
Dzavik V,
Ellis S,
Gao R,
Holmes D,
Jeong MH,
Legrand V,
Neumann F,
Nyakern M,
Spaulding C,
Stoll H,
Worthley S,
Urban P
December 30, 2011 | 10.4244/EIJV7I8A152
Effect of gender differences on early and mid-term clinical outcome after percutaneous or surgical coronary revascularisation in patients with multivessel coronary artery disease: Insights from ARTS I and ARTS II
Vaina S,
Voudris V,
Morice M,
De Bruyne B,
Colombo A,
Macaya C,
Richardt G,
Fajadet J,
Hamm C,
Schuijer M,
Macours N,
Stoll H,
Cokkinos D,
Stefanadis C,
Serruys P
January 20, 2009
Three-year follow-up of the ARTS-II# – Sirolimus-eluting stents for the treatment of patients with multivessel coronary artery disease
Serruys P,
Daemen J,
Morice M,
De Bruyne B,
Colombo A,
Macaya C,
Richardt G,
Fajadet J,
Hamm C,
Dawkins K,
Vranckx P,
Bressers M,
van Domburg R,
Schuijer M,
Wittebols K,
Pieters M,
Stoll H
January 20, 2008
Latest news
AHEAD OF PRINT
Robotic-assisted CABG: clinical outcomes
FREE ARTICLE - Aleksander Dokollari et al
November 23, 2023
PCR London Valves 2023
November 16, 2023
NEW ISSUE
PCR London Valves special edition. State-of-the-art on TMVI; the timing of TMVI; direct wire pacing for TMVR; predicting patient-prosthesis mismatch following TAVI and more
November 17, 2023
AHEAD OF PRINT
Pathophysiological CAD patterns predict outcomes post-PCI
FREE ARTICLE - Nozomi Kotoku et al
November 14, 2023
AHEAD OF PRINT
Extra-mitral valve cardiac involvement in MR
FREE ARTICLE - Antonio Popolo Rubbio et al
November 9, 2023
AHEAD OF PRINT
Cardiac damage classification in each AS subtype
FREE ARTICLE - Masaaki Nakase et al
November 6, 2023
AHEAD OF PRINT
CAPTIS embolic protection during TAVR
FREE ARTICLE - Haim D. Danenberg et al
November 2, 2023